Company Overview
Snapshot
Founded in January 2016 by Hanan Khamis, Rani B. Zananiri, Nesma Mazzawi, Asaf Romano, and Daniel Komornik, ServX operates with 1–10 employees. The company secured its Seed funding round in January 2017, attracting three investors.
Business overview
ServX is developing a novel, home-based, and real-time cervical dilation monitor. This solution aims to provide crucial information regarding the onset of active labor, suitable for both term and preterm deliveries. By reducing the need for frequent hospital visits and repeated vaginal examinations, the technology seeks to lower infection risks and enable rapid, accurate responses, ultimately guiding pregnant women to the hospital at the optimal time for safe delivery. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Monitors, targeting consumers in Demographics & Family, particularly women.
Log in to access full profile ›Company Intelligence Q&A
- What is ServX's primary product?
- ServX is developing a novel, home-based, and real-time cervical dilation monitor designed to provide crucial information about the onset of active labor for both term and preterm deliveries.
- When was ServX founded and by whom?
- ServX was founded in January 2016 by Hanan Khamis, Rani B. Zananiri, Nesma Mazzawi, Asaf Romano, and Daniel Komornik.
- What is the primary benefit of ServX's technology?
- The primary benefit of ServX's technology is to reduce the need for frequent hospital visits and repeated vaginal examinations, thereby lowering infection risks and enabling timely hospital arrival for safe delivery.
- What is ServX's product development stage?
- ServX's product is currently in the R&D stage, focusing on developing its novel, home-based, and real-time cervical dilation monitor.
- Which investors participated in ServX's Seed funding round?
- In January 2017, ServX secured Seed funding from investors including AltaIR Capital.